Astria Therapeutics, Inc.
Astria Therapeutics, Inc.
Astria Therapeutics, Inc. (ATXS) — SEC Financial Statements & Analysis
Astria Therapeutics, Inc. (ATXS) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 96 | 76 | 54 | 60 | 81 | 87 | 172 | 176 | 120 | 134 | 202 | 21 | |||||
Short Term Investments | 131 | 183 | 241 | 268 | 263 | 267 | 198 | 71 | 69 | 69 | 11 | 206 | |||||
Accounts Receivable Net Current | 17 | - | - | - | - | - | - | - | - | - | - | - | |||||
Prepaid Expense And Other Assets Current | 9 | 9 | 8 | 7 | 8 | 3 | 5 | 4 | 3 | 1 | 2 | 1 | |||||
Assets Current | 254 | 269 | 303 | 335 | 352 | 358 | 375 | 251 | 191 | 204 | 215 | 228 | |||||
Operating Lease Right Of Use Asset | 4 | 5 | 5 | 5 | 5 | 6 | 0 | 0 | 1 | 1 | 1 | 1 | |||||
Other Assets Noncurrent | 14 | 9 | 3 | 3 | 4 | 4 | 4 | 3 | 2 | 2 | 2 | 2 | |||||
Assets | 272 | 282 | 310 | 342 | 362 | 368 | 379 | 255 | 194 | 207 | 218 | 231 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 1 | 1 | 4 | 4 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | |||||
Accrued Liabilities Current | 16 | 16 | 12 | 13 | 13 | 13 | 10 | 10 | 8 | 5 | 5 | 8 | |||||
Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | |||||
Deferred Revenue Current | 4 | - | - | - | - | - | - | - | - | - | - | - | |||||
Liabilities Current | 24 | 18 | 17 | 19 | 16 | 16 | 11 | 12 | 9 | 7 | 7 | 9 | |||||
Operating Lease Liability Noncurrent | 3 | 3 | 4 | 4 | 4 | 5 | - | - | - | 0 | 0 | 0 | |||||
Deferred Revenue Noncurrent | 12 | - | - | - | - | - | - | - | - | - | - | - | |||||
Liabilities | 39 | 21 | 21 | 23 | 20 | 21 | 11 | 12 | 9 | 7 | 7 | 9 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 911 | 907 | 902 | 899 | 895 | 876 | 873 | 728 | 638 | 636 | 635 | 633 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 0 | -0 | 0 | 0 | 0 | -0 | -0 | - | - | - | -0 | -0 | |||||
Retained Earnings Accumulated Deficit | -773 | -742 | -709 | -675 | -649 | -625 | -600 | -581 | -549 | -531 | -519 | -508 | |||||
Stockholders Equity | 233 | 261 | 289 | 319 | 342 | 347 | 368 | 243 | 184 | 200 | 211 | 221 | |||||
Liabilities And Stockholders Equity | 272 | 282 | 310 | 342 | 362 | 368 | 379 | 255 | 194 | 207 | 218 | 231 | |||||
Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Nonredeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Series X Redeemable Convertible Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | |||||
Common Stock Shares Issued | 56 | 56 | 56 | 56 | 56 | 55 | 55 | 82 | 84 | 84 | 84 | 83 | |||||
Shares Outstanding | 56 | 56 | 56 | 56 | 56 | 55 | 55 | 82 | 84 | 84 | 84 | 83 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 53.59% | 48.97% | 68.21% | 13.08% | 13.08% | 89.92% | 3.03% | 2.71% | - | - | - | - |
| 2024 | -6.88% | -10.52% | 17.31% | 13.93% | 21.62% | 15.98% | -2.45% | -16.31% | -25.92% | -28.05% | -17.16% | -26.43% |
| 2023 | -6.28% | -31.21% | -26.18% | 10.14% | -7.79% | -39.93% | 20.04% | 71.94% | 191.76% | -1.30% | -36.89% | -36.75% |
| 2022 | - | - | - | - | - | - | - | - | - | -2.47% | 10.33% | 0.71% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data